Healthcare provider profile · identity verified

Michael J Gale, MD

Family Practice · SPRINGVILLE, UT · NPI 1821003138

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	462	136
Omeprazole	Omeprazole	366	107
Levothyroxine Sodium	Levothyroxine Sodium	335	93
Lisinopril	Lisinopril	248	72
Amlodipine Besylate	Amlodipine Besylate	210	62
Gabapentin	Gabapentin	196	69
Losartan Potassium	Losartan Potassium	172	52
Tamsulosin Hcl	Tamsulosin Hcl	161	50
Trazodone Hcl	Trazodone Hcl	160	48
Zolpidem Tartrate	Zolpidem Tartrate	151	25
Potassium Chloride	Potassium Chloride	126	36
Metformin Hcl	Metformin Hcl	124	46
Tramadol Hcl	Tramadol Hcl	121	28
Albuterol Sulfate Hfa	Albuterol Sulfate	119	40
Alendronate Sodium	Alendronate Sodium	112	33
Hydrochlorothiazide	Hydrochlorothiazide	109	33
Simvastatin	Simvastatin	108	35
Glipizide Er	Glipizide	105	36
Rosuvastatin Calcium	Rosuvastatin Calcium	98	32
Finasteride	Finasteride	89	25
Metoprolol Succinate	Metoprolol Succinate	85	25
Montelukast Sodium	Montelukast Sodium	82	20
Furosemide	Furosemide	77	22
Pantoprazole Sodium	Pantoprazole Sodium	76	22
Allopurinol	Allopurinol	75	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	20
Pregabalin	Pregabalin	72	13
Doxycycline Monohydrate	Doxycycline Monohydrate	71	56
Fluoxetine Hcl	Fluoxetine Hcl	70	24
Jardiance	Empagliflozin	68	12
Sertraline Hcl	Sertraline Hcl	67	23
Metformin Hcl Er	Metformin Hcl	66	18
Clonazepam	Clonazepam	65	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	62	47
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	62	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	60	suppressed
Mounjaro	Tirzepatide	57	suppressed
Meloxicam	Meloxicam	56	21
Prednisone	Prednisone	56	45
Lorazepam	Lorazepam	55	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	18
Bupropion Xl	Bupropion Hcl	52	16
Citalopram Hbr	Citalopram Hydrobromide	49	13
Sodium Chloride	0.9 % Sodium Chloride	49	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	48	12
Clopidogrel	Clopidogrel Bisulfate	48	14
Duloxetine Hcl	Duloxetine Hcl	45	11
Carvedilol	Carvedilol	43	15
Metoprolol Tartrate	Metoprolol Tartrate	41	14
Temazepam	Temazepam	41	suppressed
Atenolol	Atenolol	40	12
Ezetimibe	Ezetimibe	36	11
Lantus	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Celecoxib	Celecoxib	35	15
Triamcinolone Acetonide	Triamcinolone Acetonide	35	21
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Amoxicillin	Amoxicillin	30	27
Xarelto	Rivaroxaban	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	13
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Divalproex Sodium	Divalproex Sodium	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	15
Eliquis	Apixaban	27	11
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Fluconazole	Fluconazole	25	suppressed
Glipizide	Glipizide	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Lovastatin	Lovastatin	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	11
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Breyna	Budesonide/Formoterol Fumarate	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Cephalexin	Cephalexin	18	13
Memantine Hcl	Memantine Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Nystatin	Nystatin	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Famotidine	Famotidine	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Alogliptin	Alogliptin Benzoate	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sotalol Af	Sotalol Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Topiramate	Topiramate	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Alprazolam	Alprazolam	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error